Article
GDF5 modulation of MuSC pool as a potential therapeutic benefit for DMD
2025-10-15
Abstract excerpt
Duchenne muscular dystrophy (DMD) is a fatal disease caused by dystrophin deficiency, leading to degeneration of the entire musculature. To improve muscle pathophysiology and gene therapy for DMD, we investigated the potential of growth differentiation factor 5 (GDF5) in the DMD mdx mouse model. We showed that the overexpression of GDF5 in the muscle improved its histology, reduced inflammation, modulated regenera...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1bd6e369-0a3e-5ba0-9ed3-06f0959d468d
- DOI
- 10.1101/2025.10.14.682261
